More Ethical Generics to Compete With Originals in 2005

The current intensive campaign efforts by the Korea Association of Pharmaceutical Wholesaler (KAPW) to promote domestic ETC first and novel generics will include Pfizer Korea’s Neurontin (gabapentin) and MSD Korea’s Proscar (finasteride), starting from next year.

Pfizer Korea’s Neurontin, an anti-epilepsy treatment, recorded sales of 15.3 billion won in Year 2003 and ranked at the 32nd spot ...